Vertex Pharmaceuticals
VRTX
#146
Rank
S$177.58 B
Marketcap
S$700.42
Share price
0.85%
Change (1 day)
27.79%
Change (1 year)

Operating Margin for Vertex Pharmaceuticals (VRTX)

Operating Margin as of November 2026 (TTM): 38.68%

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 38.68%. At the end of 2022 the company had an Operating Margin of 47.39%.

Operating Margin history for Vertex Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202247.39%31.47%
202136.05%-28.23%
202050.22%49.88%
201933.51%70.13%
201819.70%-3224.19%
2017-0.63%-84.07%
2016-3.96%-92.7%
2015-54.21%-57.19%
2014-126.61%57.21%
2013-80.54%9833.53%
2012-0.81%-118.92%
20114.28%-100.81%
2010-526.35%-9.29%
2009-580.25%122.16%
2008-261.18%25.96%
2007-207.36%99.05%
2006-104.17%18.25%
2005-88.10%-34.06%
2004-133.60%-46.51%
2003-249.78%236.41%
2002-74.25%82.48%
2001-40.69%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-10.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
13.51%-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-6.41%-116.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-16.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
22.64%-41.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-76.94%-298.91%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.